ARQT - Mizuho upgrades Arcutis to buy cites Zoryve sales
2024-01-03 10:25:39 ET
More on Arcutis Biotherapeutics
- Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning
- Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript
- Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biggest stock movers today: Crypto stocks, SoFi Technologies, Bloomin' Brands and more
- Arcutis stock rallies 28% in wake of FDA approval for dermatology drug
For further details see:
Mizuho upgrades Arcutis to buy, cites Zoryve sales